Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OMIC | Common Stock | Options Exercise | $37.8K | +60K | $0.63 | 60K | Jul 7, 2022 | Direct | ||
holding | OMIC | Common Stock | 1M | Jul 7, 2022 | The Barker/Loring Trust Dated August 27, 2013 | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OMIC | Employee Stock Option (right to buy) | Options Exercise | $0 | -60K | -100% | $0.00* | 0 | Jul 7, 2022 | Common Stock | 60K | $0.63 | Direct | F2 |
Id | Content |
---|---|
F1 | The Reporting Person is the trustee of The Barker/Loring Trust and has voting and dispositive power with respect to these shares. |
F2 | Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. The option shares are fully vested and may be exercised at any time. |